平成5年
Kawakami Y, Rosenberg SA. Immunotherapy and gene therapy of human cancer using T lymphocytes. in “Cancer Chemotherapy:Challenge for the future” Excerpta Medica Tokyo..8:39-44.1993
Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule JJ, Rosenberg SA, Bennink JR. Identification of human cancers defective in antigen processing. J Exp Med.177(2):265-272.1993 Feb
Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S, Rosenberg SA. Differential expression of MAGE-1, -2,-3 mRNA in transformed and normal human cell lines. Cancer Res.53(1):5-8.1993 Jan
Kawakami Y, Nishimura MI, Restifo NP, Topalian SL, O’Neil BH, Shilyansky J, Yannelli JR, Rosenberg SA. T cell recognition of human melanoma antigens. J Immunother.14(2):88-93.1993 Aug
Restifo NP, Kawakami Y, Marincola F, Shamamian P, Taggarse A, Esquivel F, Rosenberg SA. Molecular mechanisms used by tumors to escape from immune recognition: Immunogenetherapy and the cell biology of MHC class I. J Immunother.14(3):182-190.1993 Oct
O’Neil BH, Kawakami Y, Restifo NP, Bennink JR, Yewdell JW, Rosenberg SA. Detection of shared MHC restricted human melanoma antigens following vaccinia virus mediated transduction of genes coding for HLA. J Immunol.151(3):1410-1418.1993 Aug
Kawakami Y, Haas GP and Lotzen MT. Expansion of tumor infiltrating lymphocytes from human tumors using the T cell growth factors interleukin 2 and interleukin-4.J Immunother.14(4):336-347.1993 Nov